On the basis of these results, we wanted to know whether the pathogenicity of a 2009 H1N1v isolate could be enhanced during passaging of the virus in a mammalian host system. The assumption that lung-to-lung passaging would increase pathogenicity was driven by findings of several previous reports [12] [13] [14] . Numerous studies have identified mutations within the HA [15] [16] [17] [18] and the polymerase subunits as mediators of increased pathogenicity upon passaging in mice [6, 16, [18] [19] [20] .
Here we provide evidence that 3 lung-to-lung passages of the IAV strain A/Hamburg/04/09 (HH/04) in mice were sufficient to strongly increase viral pathogenicity due to 4 nonsynonymous adaptive mutations, located within the gene segments coding for the polymerase acidic (PA) subunit (F35L) of the polymerase complex, the HA(K163E and D222G), and the neuraminidase (NA)(T32I). Using reverse genetics, we demonstrated that a single amino acid change within the PA(F35L) enhanced virulence in mice and concomitantly increased the viral polymerase activity. The sole introduction of the D222G point mutation within the HA was sufficient to increase pathogenicity in mice as well, although additional introduction of the HA(K163E) mutation further increased virulence.
Taken together, our data demonstrate that only 3 passages in mice were sufficient to alter a lowpathogenic H1N1v virus to a highly mouse-pathogenic variant with higher replication capability, which was due to the acquisition of only 3 synergistically acting point mutations. These data clearly confirm the potential risk for the emergence of highly pathogenic human H1N1v strains.
Materials and Methods

Cells, Viruses, and Infection Conditions
A/Hamburg/04/2009 virus was obtained from the German National Reference Centre for Influenza (Brunhilde Schweiger, RKI). The virus was isolated from clinical specimens, and virus strains were passaged on Madin-Darby canine kidney (MDCK) cells. The infection procedure was performed as described elsewhere [21] . The mouse-adapted A/Hamburg/04/2009 (HH/04-3rd) was obtained upon passaging 3 times in mice lungs. MDCK cells were cultured in minimal essential medium (MEM; PAA Laboratories), whereas the human lung epithelial cell line A549 was cultivated in Dulbecco's modified Eagle's medium (DMEM; PAA Laboratories). The porcine kidney epithelial (PK-15) cell line was cultured in MEM with 0.1 mmol/L nonessential amino acids (Sigma-Aldrich) and 1.0 mmol/L sodium pyruvate (PAA Laboratories), and the chicken embryonic fibroblast (DF-1) cells were cultured in DMEM with 0.1 mmol/L nonessential amino acids and 1.0 mmol/L sodium pyruvate. Cell-culture media were supplemented with 10% heat-inactivated fetal bovine serum (Invitrogen) and 100 U/mL penicillin (PAA Laboratories), and 0.1 mg/mL streptomycin (PAA Laboratories).
Generation of Recombinant Influenza Viruses
A set of 8 plasmids based on the bidirectional pHW2000 plasmid [22] was prepared for the influenza A/Hamburg/04/2009 virus by standard methods, allowing the rescue of recombinant wild-type (wt) and mutant viruses. Mutations in the gene segments were introduced by site-directed mutagenesis using the primers HA(K163E)(fwd:5′-caaagctcagcgaatcctacattaatg-3′), HA(K163E)(rev:5′-cattaatgtaggattcgctgagctttg-3′), HA(D222G)(fwd:5′-acccaaagtgaggggtcaagaagggagaa-3′), HA(D222G)(rev:5′-ttctcccttcttgacccctcactttgggt-3′), PA(F35L)(fwd:5′-aatggaacaacaagtgcctg-3′), and PA(F35L)(rev:5′-tgtgcatattgcagccaacttgttagtttcg-3′), NA(T32I)(fwd:5′-gaaacataatctcaatatggattagccactc-3′), NA(T32I)(rev:5′-gagtggctaatccatatagagattatgtttc-3′). Mutations in the PA gene segment of the SC35M virus were introduced by using the primers PA(F35L)(fwd:5′-gagacaaataaattggctgcaatatgcac-3′) and PA(F35L)(rev:5′-gtgcatattgcagccaatttatttgtctc-3′). The generation of the recombinant viruses was carried out as described elsewhere [21] , and the presence and propriety of the desired mutations were confirmed by sequencing.
Whole Genome Sequence Analysis
Total RNA was isolated from MDCK cells (6 hours; multiplicity of infection, 5) by using an RNeasyMini-Kit (Qiagen) according to the manufacturer's protocol. 
Minireplicon Luciferase Assay
Luciferase-reporter gene assays were carried out as described elsewhere [21] . A549 cells were transfected with a plasmid encoding an antisense luciferase-reporter gene flanked by the influenza virus promoters. The RNA produced by this plasmid represents a viral RNA template and is expressed by an RNA-Pol I promoter. This plasmid was transfected in addition to Pol II-driven constructs expressing the viral polymerase genes PB1, PB2, NP of the recombinant (rec) HH/04 virus strain, and PA of either the HH/04 virus strain or the rec HH/04-PA(F35L) mutant virus strain and the corresponding SC35M constructs, respectively. As a negative control, cells were transfected without any PA expression construct. Cells were lysed 24 hours posttransfection, and luciferase activities were determined.
Mouse Experiments
All animal studies were performed in compliance with animal welfare regulations (permission number Az 8,87-50.10.36.09.007 by the State Agency for Nature, Environment and Consumer Protection [LANUV], Germany). Eight-week-old BALB/c mice were obtained from the animal-breeding facilities Harlan-Winkelmann. For infection of mice, the animals were anesthetized by intraperitoneal injection of 200 μL solution of ketamine (Ceva) and xylazin (Ceva; equal amounts of 2% xylazin solution and 10% ketamine solution were mixed 1:10 with PBS). Mice were infected by the intranasal route with the indicated virus and plaque-forming units (PFU) in a 50 μL volume. In our experiments, due to protection of animal welfare restrictions, mice were killed upon a body weight loss of 25%.
For determination of lung virus titer, mice were killed at the times indicated, and lungs were collected in PBS. The samples were homogenized using a FastPrep-24 homogenizator (MP Biomedicals) with Lysing Matrix D (MP Biomedicals), and were adjusted with PBS to obtain a 10% tissue homogenate. The samples were centrifuged at 10 000 rpm for 5 minutes, and the supernatants were taken.
Structure Modeling
Images of PA proteins were created with PyMOL Molecular Graphics System, Version 1.1 (Schrödinger, LLC) with the help of the SWISS-MODEL Server [23] and the Protein Data Bank template 2w69 (Chain A+B) [24] .
Results
Adaptation of the Human H1N1v Isolate HH/04 to Mice
To investigate the potential of HH/04 to adapt to a new mammalian host, the natural human isolate was passaged 3 times in mice, whereby the emerged virus was completely sequenced. Mice infected with a high dose of 10 6 PFU did not show any symptoms of disease, consistent with a marginal body weight loss of <10% during the observation period ( Figure 1A, filled circles) . After the first passage, only a single mutation in the HA(K163E) was detectable. The isolated HH/04-1st virus was used for infection in a next passage ( Figure 1A, open circles) . Monitoring of the body weight loss revealed no differences in comparison to HH/04, illustrating that the single HA mutation (K163E) alone has no impact on virulence. Sequencing of the second passage isolate (HH/04-2nd) revealed 3 additional nonsynonymous mutations within the HA, PA, and NA, and 1 synonymous mutation within the NA gene segment ( Figure 1B ). These 3 additional mutations indeed led to enhanced pathogenicity, as evidenced by a pronounced body weight loss of HH/04-2nd-infected mice ( Figure 1A , open squares). Subsequent sequencing of the third passage isolate (HH/04-3rd) revealed that the previously emerged mutations were stable without any appearance of further mutations.
Increased Pathogenicity of the Mouse-Adapted HH/04-3rd Isolate
In contrast to the HH/04 virus, infection of mice with the HH/04-3rd-passage isolate resulted in increased body weight loss ( Figure 2A ) and enhanced lung virus titers ( Figure 2B ), which was accompanied by 80% lethality ( Figure 2C ). Our results clearly indicate that the almost apathogenic human HH/04 isolate can be adapted to a new mammalian host after only 2-3 lung-to-lung passages.
Mutations Within the Hemagglutinin and the PA Subunit of the Polymerase Complex Are Responsible for Enhanced Mouse Pathogenicity
We generated a recombinant 8 plasmid set for the recovery of recombinant HH/04 viruses. The identified nonsynonymous mutations were introduced separately or in combination into the genome of 9 recombinant HH/04 viruses, designated as rec HH/04, rec HH/04-3rd, and HH/04-HA(K163E); HH/04-HA(D222G); HH/04-PA(F35L) and HH/04-NA(T32I). Furthermore, the HH/04-HA(K163E+D222G) variant, containing both mutations in the HA, HH/04-HA(K163E+D222G) PA(F35L), and HH/04-HA(K163E+D222G) NA(T32I) mutants carrying the indicated changes were created. To show that the introduction of the 4 mutations in HH/04 reflects the phenotype of the 3rd-passage HH/04, the weight loss ( Figure 3A ) and lung virus titers ( Figure 3B ) of mice infected with HH/04, rec HH/04, HH/04-3rd, and rec HH/04-3rd were determined. Both parameters were almost identical when HH/04 was compared with rec HH/04 and HH/04-3rd to rec HH/04-3rd, respectively. Thus, the recombinant virus and the genetically engineered variant exhibited a similar replication behavior and pathogenicity as their natural counterparts.
To analyze the impact on virulence of each single adaptive mutation, mice were infected with rec HH/04 and 4 virus mutants, each containing the indicated single mutation ( Figure 4A ). By monitoring body weight loss, a strong contribution of the HA(D222G) and PA(F35L) mutations to increased virulence was detected. In contrast, the HA(K163E) and NA(T32I) mutations alone did not affect viral pathogenicity to a large extent. In contrast, examination of double-and triple-mutant viruses revealed a supplementary contribution of the HA(K163E), and just to a minor extent, of the NA(T32I) mutation to increased virulence ( Figure 4B ). In this low-dose infection experiment, the rec HH/04-HA(K163E+D222G) PA(F35L) virus indeed showed higher additive effects of the PA(F35L) mutation compared with the NA(T32I) mutation for virulence, although the NA(T32I) impact on virus virulence cannot completely be neglected.
PA(F35L)-Dependent Increase of Virulence Correlates With Enhanced Viral Polymerase Activity
As part of the heterotrimeric RNA-dependent RNA polymerase, the PA contributes to diverse functions such as endonuclease and protease activities, cap-binding, and cap-snatching, as well as viral RNA binding [24] [25] [26] [27] [28] . A likely explanation for enhanced pathogenicity of the HH/04-PA(F35L) variant could be that the PA mutation confers enhanced polymerase activity. We studied the polymerase activity of the HH/04-PA(F35L) virus in comparison to the rec HH/04 strain in a minireplicon assay, allowing the relative quantification of viral polymerase activity. Reconstitution of the polymerase complex with a PA containing the F35L mutation resulted in a 2.5-fold higher polymerase activity compared with the PAwt protein ( Figure 5A ). This was not a strain-specific phenomenon because the same mutation in the background of the avian influenza virus A/Seal/Massachusetts/1/80 (H7N7) mouse-adapted strain (SC35M; Figure 5B ) showed a similar result. To examine whether this enhanced polymerase activity improves the replication efficiency, different cell lines were infected with the rec HH/04 and rec HH/04-PA(F35L). Viral protein accumulation and virus propagation were examined by determination of the viral M1-protein synthesis and progeny virus titers. Upon infection with HH/04-PA(F35L), an increase of both viral protein amounts ( Figure 5C ) and virus titers ( Figure 5D ) was detected. This phenomenon was not dependent on the cell type used because infection of different cell lines resulted in a similar increase in polymerase activity if the F35L mutation was present in the PA. Taken together, these results clearly indicate a replication advantage conferred by the F35L mutation in the PA, which is most likely the molecular basis for enhanced virulence in PA(F35L)-infected mice.
Discussion
Adaptation is a major driving force in evolution, whereby beneficial mutations within the genome become manifest and result in adaptation to a novel host, accompanied by increased fitness and enhanced propagation. Taking this into account, it is likely that pandemic H1N1 viruses may acquire enhanced virulence caused by adaptive mutations during propagation and spreading among humans and/or pigs.
In the present study, the mouse-adapted virus strain showed increased pathogenicity illustrated by increased body weight loss and mortality, as well as increased replication capacity in mice lungs (Figure 2A-C) . Four nonsynonymous mutations were identified via whole genome sequence analysis ( Figure 1B ). Among these, 3 mutations within the PA and the HA were recognized as a cause of the increased pathogenicity. The aspartic acid to glycine exchange D222G within the hemagglutinin of 2009 H1N1v viruses could be epidemiologically correlated to severe cases of illness in several countries [29] [30] [31] . In 1 out of 6 H1N1v-infected patients with primary severe respiratory failure treated at the intensive care unit of the university hospital Muenster in 2009, we were able to demonstrate that the HA(D222G) mutation arose simultaneously with the oseltamivir resistance mutation H275Y in the NA (data not shown). In this 31-year-old previously healthy male patient, virus isolated on day 1 after admission and initiation of the oseltamivir treatment (influenza A/Nordrhein-Westfalen/172/09, RKI) still contained the wt sequence (HA D222, NA H275) and was phenotypically oseltamivir sensitive. In a subsequent isolate obtained on day 5 after admission and completion of the oseltamivir therapy (influenza A/Nordrhein-Westfalen/173/09) and in all following isolates, the respective mutations were present and isolates were phenotypically oseltamivir resistant. This case clearly highlights the existing risk of further adaptation, leading to high virulent and nondrug-treatable virus variants. A D222G change in the HA protein of pandemic 2009 IAV led to broader binding range of alpha 2,3-linked sialyl receptor sequences [32, 33] .
In mice, the D222G mutation is related to higher virus titers, elevated proinflammatory cytokine release in the lungs, and enhanced lethality [34] . Furthermore, similar H1N1v mice adaptation approaches detected the HA(D222G) mutation as well [35, 36] , possibly indicating the necessity of an α 2,3-linked sialyl receptor binding specificity for efficient replication in mice [37] . It is conspicuous that mutations in the HA were most often accompanied by mutations within the polymerase complex, especially in the PA protein [35, 36, 38] . These data are in line with our results regarding the importance of the HA(D222G) mutation for the virulence of pandemic H1N1 viruses. Nevertheless, body weight loss of rec HH/04-HA(D222G)-infected mice was less severe as of rec HH/04-3rd-infected mice (Figure 4B ), revealing the strong involvement of further mutations contributing to the increased virulence, which highlights synergistic effects of several mutations in combination.
The increase of virulence due to the HA(D222G) mutation is further enhanced by introduction of the HA(K163E) mutation, as indicated by the increased body weight loss of HA(K163E+D222G) double mutant-infected mice ( Figure 4B ). Similar to the amino acid at position 222 in the HA, the amino acid at position 163 is described as an antigenic site in H1-HA. Whereas amino acid 222 is located in the Ca epitope, amino acid 163 is closely located to the receptor-binding site in the Sa epitope [39, 40] . Additional introduction of either the PA or the NA mutation to the double-mutant virus revealed a stronger contribution of PA mutation to increased virulence as against the NA mutation, as it was expected from the single-mutant infection studies ( Figure 4A ).
During the virus life cycle, the PA protein is mainly responsible for transcription and replication of the viral RNA. The messenger RNA (mRNA) caps are snatched 10-14 nucleotides behind the 5′ cap from host pre-mRNAs by a distinctive, still not fully dissolved mechanism [41] [42] [43] [44] . Recently, it was shown that the endonuclease activity of the polymerase complex is located in the N-terminal part of the PA subunit [24, 28] . These functions of the PA led us to the concept that enhanced body weight loss of mice could be due to more efficient virus propagation caused by increased polymerase activity. Indeed, the polymerase activity of PA(F35L) viruses outperformed 2 wild-type viruses of the H1 and H7 subtypes by 2-to 2.5-fold in a minireplicon assay ( Figure 5A and 5B). Consistent with this finding, the increased polymerase activity also led to enhanced replication efficiency in cultured cells from different species.
The concept of optimized interactions among viral proteins and host cell factors as being partially responsible for adaptation to a new host was reported to be a determinant of host range [45] . At present, we cannot exclude that the PA(F35L) mutation improves the activity of the viral polymerase by enhancing its association with host cell factors in mice. However, given the result that the PA(F35L) variation increases viral polymerase activity in both human and murine cells ( Figure 5C and 5D) , we favor the hypothesis that this variation rather functions in a host-independent manner, possibly by improving the catalytic activity of the viral enzyme. Although precise and entire functions of PA still remain unclear, the PA is known to contribute to several steps during the replication process. Thus, numerous functions can be affected by the F35L mutation improving polymerase activity. The Nterminus of HH/04-PA displays amino acid 35 to be located in the α-helix 3, as shown in the computationally 3-dimensional (3D) structure prediction approach ( Figure 6A and 6B ).
This amino acid is closely located to histidine 41, which is part of the endonuclease active site and seems to be responsible for binding of divalent cations [24, 28] . The structure prediction of the PA(L35) protein reveals an unaltered protein structure and also no apparent change in the orientation of the marked residues. Sequence alignment of 2 representative IAV (H3N2 and H5N1) strains [24] reveals conserved sequences from amino acid 29 throughout the whole α-helix 3 of both strains, comparable to HH/04. Leucine at position 35 matches to the consensus sequence of influenza B viruses that also contain an identical H41 active site residue. Apart from that, a sequence alignment of human IAV strains (National Center for Biotechnology Information Influenza Virus Resource Database) reveals 8 pandemic 2009 H1N1 strains, comprising the amino acid leucine at position 35 within the PA. In addition to the 8 pandemic 2009 H1N1 strains, the mutation also emerged in 2 strains isolated in the forties and in 2 high-virulent H5N1 human isolates. These data clearly highlight the possibility of natural occurrence of the PA(F35L) mutation in humans, emphasizing the potential risk of the emergence of highly virulent pandemic H1N1 viruses in humans.
It would be interesting to know whether the emerged adaptive mutations originate de novo or were selected from preexisting quasispecies. Because the study was initiated with a natural isolate that was obtained by an oral cavity swap of an infected patient, the existence of quasispecies within the inoculum cannot be totally ruled out. A closer look on the sequencing chromatograms of the HA (position 163) and NA (position 32) in the origin strain possibly reveals mixed populations within the inoculum ( Figure 1B) . However, similar to the natural isolate, enhanced pathogenicity in mice also was observed after 3 passages of the genetically defined recombinant HH/04, where quasispecies do not play a role (data not shown). Thus, although selection of quasispecies may occur, there is also de novo selection of variants.
In summary, this new HH/04-3rd variant is characterized by increased virulence primarily due to HA(K163E), HA(D222G), and the PA(F35L) mutations, which can be defined as pathogenicity determinants that are mainly responsible for enhanced virulence. Our data furthermore clearly illustrate that the examination of single-pathogenicity determinants for the assessment of enhanced viral pathogenicity can be somehow insufficient, highlighting the need to take the synergistic action of pathogenicity determinants for increased virulence into account. In these adaptation approaches, 2 events seem to have occurred for adaptation of pandemic 2009 H1N1v strains to mice. On the one hand, an optimized HA-dependent receptor binding specificity (probably leading to changes in attachment to different cell types [32, 37] ), and on the other hand, increased replication efficiency (resulting in an enhanced virus propagation) is required for manifestation of an efficient infection. The RNA produced by this plasmid represents a viral RNA template and is expressed via RNA-Pol I promoter. This plasmid was transfected in addition to Pol II-driven constructs expressing the viral polymerase genes PB1, PB2, and NP of (A ) the recombinant (rec) HH/04 strain and PA of either the rec HH/04 strain or the rec HH/04-PA(F35L) mutant strain. In (B ), instead of the influenza rec HH/04 virus constructs, the corresponding constructs of the influenza A/Seal/Massachusetts/1/80 (H7N7) mouse-adapted virus strain were applied. As negative control, cells were transfected without any PA expression construct. Cells were lysed 24 hours posttransfection, and luciferase activities were determined. The value obtained with the PA-wt plasmid set was arbitrarily set to 100%. C, D, A549 cells, chicken embryonic fibroblast (DF-1) cells, porcine kidney epithelia cells (PK-15), and mouse pulmonary squamous cell carcinoma cells (ASB-XIV) were infected with a multiplicity of infection of 1 of either rec HH/04 or rec HH/04-PA(F35L). Eight hours postinfection, viral M1-protein accumulation was detected by Western blot analysis (C ), and virus titers were determined in standard plaque titrations (D 
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